An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level

Journal of Urology

Volumn 156, Issue 4, 1996, Pages 1375-1380

  Badalament, Robert A ^a   Miller, M Craig ^a   Peller, Paul A ^a   Young, Donn C ^a   Bahn, Duke K ^a   Kochie, Paul ^a   O'Dowd, Gerard J ^a   Veltri, Robert W ^a  

^a NONE

Author keywords

algorithms; biopsy; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SCORING SYSTEM;

EID: 0029795393     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65590-3     Document Type: Article

References (23)

1. Badalament, R. A., O'Toole, R. V., Young, D. C. and Drago, J. R.: DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Cancer, 67: 3014, 1991.
2. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
3. Paulson, D. F.: Impact of radical prostatectomy in the management of clinically localized disease. J. Urol., part 2, 152: 1826, 1994.
4. Walsh, P. C., Partin, A. W. and Epstein, J. I.: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., part 2, 152: 1831, 1994.
5. Catalona, W. J. and Smith, D. S.: 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol., part 2, 152: 1837, 1994.
6. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. and Scardino, P. T.: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol., part 2, 152: 1843, 1994.
7. Hammerer, P., Huland, H. and Sparenberg, A.: Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinoma. Eur. Urol., 22: 281, 1992.
8. Peller, P. A., Young, D. C., Marmaduke, D. P., Marsh, W. L. and Badalament, R. A.: Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer, 75: 530, 1995.
9. Gleason, D. F.: Histologic grade, clinical stage, and patient age in prostate cancer. Natl. Cancer Inst. Monogr., 7: 15, 1988.
10. Bacus, S. S., Bacus, J. W., Bacus, J. V., Chin, D. M., Ortiz, R., Stern, R. K. and Morrow, D. W.: Prostate adenocarcinoma: an analysis technique for DNA ploidy determination. Lab. Med., 24: 225, 1993.
11. Veltri, R. W., Partin, A. W., Epstein, J. I., Marley, G. M., Miller, C. M., Singer, D. S., Patton, K. P., Criley, S. R. and Coffey, D. S.: Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. J. Cell. Biochem., suppl., 19: 249, 1994.
12. McNeal, J. E.: Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum. Path., 23: 258, 1992.
13. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
14. Hosmer, D. W., Jr. and Lemeshow, S.: Applied Logistic Regression. New York: John Wiley & Sons, 1989.
15. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol., 142: 71, 1989.
16. Terris, M. K., McNeal, J. E. and Stamey, T. A.: Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J. Urol., 148: 829, 1992.
17. Villers, A., McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J. Urol., 142: 763, 1989.
18. Lee, F., Bahn, D. K., McHugh, T. A., Onik, G. M. and Lee, F. T., Jr.: US-guided percutaneous cryoablation of prostate cancer. Radiology, 192: 769, 1994.
19. Epstein, J. I., Pizov, G., Steinberg, G. D., Carter, H. B., Pitcock, R., Armas, O. A., Partin, A. and Walsh, P. C.: Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape, and Gleason grade with pathological stage at radical prostatectomy. J. Urol., 148: 87, 1992.
20. Partin, A. W., Walsh, P. C., Pitcock, R. V., Mohler, J. L., Epstein, J. I. and Coffey, D. S.: A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J. Urol., 142: 1254, 1989.
21. Dawson, A. E., Cibas, E. S., Bacus, J. W. and Weinberg, D. S.: Chromatin texture measurement by Markovian analysis. Use of nuclear models to define and select texture features. Anal. Quant. Cytol. Histol., 15: 227, 1993.
22. Carmichael, M. J., Veltri, R. W., Partin, A. W., Miller, M. C., Walsh, P. C. and Epstein, J. I.: Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. J. Urol., part 2, 153: 1015, 1995.
23. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.